Sunday, September 29, 2024
HomeNews

News

CymaBay Announces FDA Acceptance of NDA and Priority Review for Seladelpar for the Treatment of Primary Biliary Cholangitis

CymaBay Therapeutics, Inc., a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, announced that the U.S. Food and...

Tyber Medical Acquires FDA Clearance for Proximal Tibia Plating System

Tyber Medical LLC, a leading orthopedic device manufacturer providing private label orthopedic implants for the trauma, extremity, and spine markets, has received a U.S....

Cadence and Dassault Systèmes Unveil the First Cloud-Enabled, Collaborative Experience to Transform the Development of Electromechanical Systems

Cadence Design Systems, Inc. and Dassault Systèmes, announced at 3DEXPERIENCE World that they have extended their ongoing strategic partnership by integrating the AI-driven Cadence...

Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced a definitive agreement under which Gilead will acquire CymaBay for $32.50 per share in cash or...

Intuitive Machines and SpaceX Complete Successful IM-1 Test Campaign

Intuitive Machines, Inc., a leading space exploration, infrastructure, and services company, and SpaceX have analyzed the data from the lunar lander fueling tests for...
0FansLike
0FollowersFollow
spot_img

Hot Topics